CROSSROADS STRATEGIES, LLC for MERCK & CO., INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues related to the Trans-Pacific Partnership (TPP).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax reform. Issues related to Treasury regulations on Section 385.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Health Issues HCR
Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148) and the Food and Drug Administration Safety and Innovation Act (P.L.112-144). H.R.512, DISARM Act of 2015. H.R.34, 21st Century Cures Act (P.L.114-255). S.2912, Trickett Wendler Right to Try Act 2016. Issues related to health care, the Food and Drug Administration (FDA), 340B Program, animal health and oncology coverage. P.L.114-328, National Defense Authorization Act for Fiscal Year 2017, vaccine provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid. H.R.5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models; issues related to Demonstration Programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Budget/Appropriations BUD
H.R.5054/S.2956, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; S.3040/H.R.5926, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; reimbursement issues; vial size issues. H.R.5293/S.3000, Department of Defense Appropriations Act, 2017; Tricare formulary issues. H.R.2028, Further Continuing and Security Assistance Appropriations Act, 2017 (P.L.114-254).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| ELIZABETH ALYSON HART | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| JAKE PERRY | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.